Lv3
230 积分 2022-03-24 加入
In vivo CAR T cells move into clinical trials
1天前
已完结
In vivo hematopoietic stem cell modification by mRNA delivery
9个月前
已完结
Chemistry of Lipid Nanoparticles for RNA Delivery
9个月前
已完结
Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook
10个月前
已完结
Chimeric nanobody-decorated liposomes by self-assembly
10个月前
已完结
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells
10个月前
已完结
Enhanced Penetration and Retention of CuS‐Based Nanosystem Through NIR Light and In Situ Enzyme Response for Improved Tumor Therapy
10个月前
已完结
Industry update: the latest developments in the field of therapeutic delivery, November 2021
11个月前
已完结
Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines
1年前
已完结
In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift
1年前
已完结
皖公网安备34019202002308
